![H & T Group](/common/images/company/AQSE_HAT.GB.png)
MARIETTA, Ga., July 31, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of HELIOGEN™ Fibrillar Collagen Matrix, a...
Net Sales of $87 Million Grew 7% Year-Over-Year for the Second Quarter Second Quarter GAAP Net Income and Earnings Per Share were $18 Million and $0.12, Respectively Second Quarter Adjusted EBITDA...
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first...
MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the...
MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5 | -1.2987012987 | 385 | 388 | 360.5 | 1873 | 370 | DE |
4 | 4.5 | 1.19840213049 | 375.5 | 400 | 360.5 | 2025 | 375.41618097 | DE |
12 | -45 | -10.5882352941 | 425 | 429 | 360.5 | 1832 | 385.48656825 | DE |
26 | 15 | 4.1095890411 | 365 | 436.78 | 335.5 | 3653 | 388.02712186 | DE |
52 | -56 | -12.8440366972 | 436 | 496.5 | 302.78 | 3827 | 400.07761238 | DE |
156 | 113 | 42.3220973783 | 267 | 503.8 | 260.5 | 3792 | 377.21475673 | DE |
260 | 17 | 4.68319559229 | 363 | 503.8 | 195.52 | 6556 | 316.4192105 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.